Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, PhaseIITrial

Authors
Category Primary study
JournalARTHRITIS & RHEUMATOLOGY
Year 2020
This article has no abstract
Epistemonikos ID: d7bcd128dee479f0c469ee9606d8bd4419c2353a
First added on: Apr 06, 2025